Research progress of gut microbiota and its metabolites in polycystic ovary syndrome.
1/5 보강
Polycystic ovary syndrome (PCOS) ranks among the most widespread endocrine and metabolic conditions affecting women of childbearing age, but its specific pathogenesis remains unknown.
APA
Qin S, Guo S, et al. (2025). Research progress of gut microbiota and its metabolites in polycystic ovary syndrome.. Frontiers in endocrinology, 16, 1700191. https://doi.org/10.3389/fendo.2025.1700191
MLA
Qin S, et al.. "Research progress of gut microbiota and its metabolites in polycystic ovary syndrome.." Frontiers in endocrinology, vol. 16, 2025, pp. 1700191.
PMID
41480369
Abstract
Polycystic ovary syndrome (PCOS) ranks among the most widespread endocrine and metabolic conditions affecting women of childbearing age, but its specific pathogenesis remains unknown. More and more evidence indicates that PCOS may be a complex polymorphic disease, influenced by epigenetic and environmental factors, including diet and lifestyle. This review focuses on the role of the gut microbiota and its metabolites in PCOS, a topic that has gained significant attention recently due to the established link between the gut microbiome and metabolic disorders.
🏷️ 키워드 / MeSH
같은 제1저자의 인용 많은 논문 (5)
- Intratumoral spatial heterogeneity at non-contrast CT predicts histological grading of invasive pulmonary adenocarcinoma: a multicenter retrospective study.
- Evaluation of T1 and T2 mapping for non-invasive assessment of HER2 and PD-L1 expression in bladder cancer.
- Heavy metal exposure and cancer risk: Findings from a Mendelian randomization study.
- First-Line Pembrolizumab Plus Chemotherapy for HER2-Negative Advanced Gastric Cancer: China Subgroup Analysis of the Randomized Phase 3 KEYNOTE-859 Study.
- A Case Report of Primary Pulmonary Lymphoepithelioma-Like Carcinoma with "Harmful" Pseudoprogression and a Pathological Complete Response (pCR) after Immunotherapy Plus Radiotherapy.